InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Pellini Michael J, Director. Director active across 3 companies, notably Singular Genomics Systems, Inc.. In total, 7 disclosures have been logged. Total volume traded: €85k. The latest transaction was filed on 31 May 2022 — Levée d'options. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations7 total
€11,91460,668 shares@ €0.196412.4% of flow
Common Stock
SEC:0001209191-22-034752:0·
€84,55526,834 shares@ €3.15187.6% of flow
Common Stock
SEC:0001209191-22-030584:0·
Ideal exit: 12 Feb 2023 (T+270)
12,836 shares
Class A Common Stock
SEC:0001209191-22-028693:0·
06,689 shares0
Common Stock
SEC:0001209191-22-005499·
06,689 shares0
Common Stock
SEC:0001209191-22-005499:0·
96,944 shares
Common Stock
SEC:0001209191-21-037021·
96,944 shares
Common Stock
SEC:0001209191-21-037021:0·
7 of 7 declarations
About Pellini Michael J
Pellini Michael J serves as a Board Member at Singular Genomics Systems, Inc., Adaptive Biotechnologies Corp, and Sema4 Holdings Corp. In this role, he oversees operations and participates in strategic decision-making. His expertise in the biopharmaceutical sector is essential in guiding the companies towards sustainable growth.
